Pharmagen ApS: Financial statements 2018
CVR: 36687193
Source: annual report 2018, Danish Business Authority
01/10/2017 – 30/09/2018
Pharmagen ApS (CVR 36687193) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 344,900 and a net result of DKK -236,511 compared with DKK 269,922 the year before. That is a decrease of 3.3% compared with the year before. Equity in the 2018 report amounted to DKK 382,507. The solvency ratio was 25.8%.
- Gross Profit
- DKK 344,900
- Profit/Loss
- DKK -236,511
- Equity
- DKK 382,507
- Total Assets
- DKK 1,479,767
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 345 t. | -237 t. | 383 t. | - |
| 2017 | - | 357 t. | 270 t. | 619 t. | - |
| 2016 | - | 397 t. | 296 t. | 349 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Pharmagen ApS has published its annual report for 2017. Gross profit came to DKK 356,650, and the net result was DKK 269,922.
About Pharmagen ApS
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.